Jon Caulkins's guest appearances

Jon Caulkins

Heinz Radio

Addiction Audio

The History of Drugs In Society

Ijeoma Oluo

Paul Triolo

Andrew Jones

Sam Quinones

Emma Johnson

Cesar Chavez

Taylor Lorenz

Dan O'Brien

Jack Wilson

Laura Norén

David Danks

Chris Cox

Adam Ficek

Brett Crawford

Michael Arnold

OwlTail

Rob Calder speaks to Professor Jon Caulkins about his Addiction Opinion &amp; Debate article discussing the difficulties of measuring heroin use with general population surveysReuter P, Caulkins JP, Midgette G. Heroin Use Cannot Be Measured Adequately with a General Population Survey. Addiction 2021 https://doi.org/10.1111/add.15458 See acast.com/privacy for privacy and opt-out information.

Rob Calder speaks to Professor Jon Caulkins about his Addiction Opinion &amp; Debate article discussing the difficulties of measuring heroin use with general population surveysReuter P, Caulkins JP, Midgette G. Heroin Use Cannot Be Measured Adequately with a General Population Survey. Addiction 2021 <a href="https://doi.org/10.1111/add.15458" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1111/add.15458</a> See <a href="https://acast.com/privacy" rel="noopener noreferrer nofollow" target="_blank">acast.com/privacy</a> for privacy and opt-out information.

Heroin use and general population surveys with Jon Caulkins

Hello and welcome to the History of Drugs in Society, where we explore the history of different substances and how we’ve lived alongside and interacted with them. I’m your host, Eugene Leventhal.  If you’re interested in learning more about how fentanyl markets came about and how they look like today, you should enjoy this discussion. In this episode, I interview Jon Caulkins, who is a University Professor Of Operations Research And Public Policy at Carnegie Mellon University’s Heinz College. Our interview focuses on fentanyl in the United States, looking at both the history and current state of fentanyl market. We talk about the impact of COVID-19 on fentanyl markets, what evidence there has been of fentanyl being mixed with other drugs, and what a term like morphine equivalent dose means and why it’s important to know. We also touch on safe supply, regional and international trends in synthetic opioid usage, and where data on overdoses come from.  Pulling from his bio on the Heinz College site, “Jon Caulkins has been on the Heinz College faculty since 1990, with leaves of absence to be co-director of RAND’s Drug Policy Research Center in Santa Monica (1994-1996), to found RAND’s Pittsburgh Office (1999-2001), and to teach at Carnegie Mellon’s campus in Doha, Qatar (2005-2011).     Here is the link to the UN report mention https://news.un.org/en/story/2020/05/1063512 Other links: https://www.rand.org/ http://www.issdp.org/ 

Hello and welcome to the History of Drugs in Society, where we explore the history of different substances and how we’ve lived alongside and interacted with them. I’m your host, Eugene Leventhal.  If you’re interested in learning more about how fentanyl markets came about and how they look like today, you should enjoy this discussion. In this episode, I interview Jon Caulkins, who is a University Professor Of Operations Research And Public Policy at Carnegie Mellon University’s Heinz College. Our interview focuses on fentanyl in the United States, looking at both the history and current state of fentanyl market. We talk about the impact of COVID-19 on fentanyl markets, what evidence there has been of fentanyl being mixed with other drugs, and what a term like morphine equivalent dose means and why it’s important to know. We also touch on safe supply, regional and international trends in synthetic opioid usage, and where data on overdoses come from.  Pulling from his bio on the Heinz College site, “Jon Caulkins has been on the Heinz College faculty since 1990, with leaves of absence to be co-director of RAND’s Drug Policy Research Center in Santa Monica (1994-1996), to found RAND’s Pittsburgh Office (1999-2001), and to teach at Carnegie Mellon’s campus in Doha, Qatar (2005-2011). Here is the link to the UN report mention <a href="https://news.un.org/en/story/2020/05/1063512" rel="nofollow" target="_blank">https://news.un.org/en/story/2020/05/1063512</a> Other links: <a href="https://www.rand.org/" rel="nofollow" target="_blank">https://www.rand.org/</a> <a href="http://www.issdp.org/" rel="nofollow" target="_blank">http://www.issdp.org/ </a>

7. Fentanyl with Prof. Jon Caulkins

In this episode, Kee Won Song speaks with Jon Caulkins, Heinz College professor of management science and decision analysis. They discuss Dr. Caulkins’ varied experiences as faculty member, consultant, and policy researcher and co-director for RAND. Dr. Caulkins speaks about how he found his niche in drug policy research, talks about the massive structural change marijuana legalization will have on the market, and explains why RAND chose to open an office in Pittsburgh. Lastly, they speak about Dr. Caulkins’ time teaching at the Qatar campus and he offers some basic info about the student body and specifics of that campus.

In this episode, Kee Won Song speaks with Jon Caulkins, Heinz College professor of management science and decision analysis. They discuss Dr. Caulkins’ varied experiences as faculty member, consultant, and policy researcher and co-director for RAND. Dr. Caulkins speaks about how he found his niche in drug policy research, talks about the massive structural change marijuana legalization will have on the market, and explains why RAND chose to open an office in Pittsburgh. Lastly, they speak about Dr. Caulkins’ time teaching at the Qatar campus and he offers some basic info about the student body and specifics of that campus.

Modeling and Marijuana Legalization with Jon Caulkins